FDA Inspection 1251732 — Penn Medicine Lancaster General Hospital
The FDA completed an inspection of Penn Medicine Lancaster General Hospital on Sep 20, 2024 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lancaster, PA (United States)